Expression of stromal cell-derived Factor-1/Pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34(+) human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors

Citation
T. Ishii et al., Expression of stromal cell-derived Factor-1/Pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34(+) human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors, J IMMUNOL, 163(7), 1999, pp. 3612-3620
Citations number
50
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
163
Issue
7
Year of publication
1999
Pages
3612 - 3620
Database
ISI
SICI code
0022-1767(19991001)163:7<3612:EOSCFC>2.0.ZU;2-N
Abstract
We found that the stromal cell-derived factor-1/pre-B cell growth-stimulati ng factor receptor, CXC chemokine receptor 4 (CXCR4), is expressed on human CD34(+) bone marrow (BM) cells. Stringently FAGS-sorted CD34(+)CXCR4(+) BM cells completely lack myeloid, erythroid, megakaryocytic, and mixed colony -forming potential (myeloid progenitors), but give rise to B and T lymphoid progenitors, whereas CD34(+)CXCR4(-) BM cells can generate colonies formed by myeloid progenitors and can also develop into these lymphoid progenitor s. Therefore, expression of CXCR4 on CD34(+) BM cells can allow lymphoid pr ogenitors to be discriminated from myeloid progenitors. Because CD34(+)CXCR 4(+) cells are differentiated from CD34(+)CXCR4(-) cells, multipotential pr ogenitors located in the BM are likely to be negative for CXCR4 expression. CXCR4 seems to be expressed earlier than the IL-7R and terminal deoxynucle otidyl transferase during early lymphohemopoiesis. These results suggest th at the expression of CXCR4 on CD34(+) BM cells is one of the phenotypic alt erations for committed lymphoid progenitors.